VOYA Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $6.42K | Sell |
|
|||||
|
2024
Q4 | $28.4K | Hold |
|
|||||
|
2024
Q3 | $60.3K | Sell |
|
|||||
|
2024
Q2 | $66.6K | Buy |
|
|||||
|
2024
Q1 | $69.5K | Sell |
|
|||||
|
2023
Q4 | $57.2K | Hold |
|
|||||
|
2023
Q3 | $40.7K | Hold |
|
|||||
|
2023
Q2 | $85.6K | Buy |
|
|||||
|
2023
Q1 | $79.4K | Hold |
|
|||||
|
2022
Q4 | $62.4K | Hold |
|
|||||
|
2022
Q3 | $78.4K | Buy |
|
|||||
|
2022
Q2 | $49K | Sell |
|
|||||
|
2022
Q1 | $65K | Buy |
|
|||||
|
2021
Q4 | $115K | Buy |
|
|||||
|
2021
Q3 | $129K | Hold |
|
|||||
|
2021
Q2 | $124K | Buy |
|
|||||
|
2021
Q1 | $120K | Sell |
|
|||||
|
2020
Q4 | $76K | Buy |
|
|||||
|
2020
Q3 | $19K | Hold |
|
|||||
|
2020
Q2 | $26K | Sell |
|
|||||
|
2020
Q1 | $43K | Hold |
|
|||||
|
2019
Q4 | $91K | Buy |
|
|||||
|
2019
Q3 | $52K | Hold |
|
|||||
|
2019
Q2 | $109K | Hold |
|
|||||
|
2019
Q1 | $96K | Hold |
|
|||||
|
2018
Q4 | $115K | Hold |
|
|||||
|
2018
Q3 | $185K | Hold |
|
|||||
|
2018
Q2 | $208K | Sell |
|
|||||
|
2018
Q1 | $169K | Sell |
|
|||||
|
2017
Q4 | $10.5M | Sell |
|
|||||
|
2017
Q3 | $14.2M | Buy |
|
|||||
|
2017
Q2 | $14.4M | Buy |
|
|||||
|
2017
Q1 | $10.3M | Buy |
|
|||||
|
2016
Q4 | $7.17M | Buy |
|
|||||
|
2016
Q3 | $9.37K | Sell |
|
|||||
|
2016
Q2 | $7.64M | Sell |
|
|||||
|
2016
Q1 | $8.98M | Buy |
|
|||||
|
2015
Q4 | $9.76M | Sell |
|
|||||
|
2015
Q3 | $10.3M | Buy |
|
|||||
|
2015
Q2 | $160K | Sell |
|
|||||
|
2015
Q1 | $131K | Hold |
|
|||||
|
2014
Q4 | $127K | Hold |
|
|||||
|
2014
Q3 | $196K | Hold |
|
|||||
|
2014
Q2 | $224K | Hold |
|
|||||
|
2014
Q1 | $241K | Hold |
|
|||||
|
2013
Q4 | $251K | Hold |
|
|||||
|
2013
Q3 | $330K | Hold |
|
|||||
|
2013
Q2 | $302K | Buy |
|